# Carter BloodCare – FDA Inspection, Aug 25, 2017

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare/7c649d44-390b-4689-b634-469600b3fd89
Source feed: FDA_Inspections

> FDA inspection 1023814 of Carter BloodCare, August 25, 2017. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1023814
- Company Name: Carter BloodCare
- Inspection Date: 2017-08-25
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1329542 - 2026-07-21
- FDA Inspection 1092617 - 2019-05-23
- FDA Inspection 938894 - 2015-07-10
- FDA Inspection 818232 - 2013-02-13
- FDA Inspection 706855 - 2011-01-13

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/decarlos-a-gomez/4b003235-edbb-4cb5-acb1-4e154941578c)

Company: https://www.keypedia.com/companies/carter-bloodcare/9ad4f15c-23c0-41af-a70c-ef89efa313a8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d